CD40 ligand expression on stimulated T-helper lymphocytes in patients with common variable immunodeficiency

Iranian Journal of Allergy, Asthma and Immunology

Volumn 6, Issue 3, 2007, Pages 129-135

  Ravanbakhsh, Masoud ^a   Sarafnejad, Abdolfatah ^a   Aghamohammadi, Asghar ^b   Kardar, Gholam Ali ^b   Omran, Hossein Asgarian ^a   Atarod, Lida ^c   Rezaei, Nima ^b   Shahrestani, Tahereh ^a   Hosseini, Mostafa ^a   Moin, Mostafa ^b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

CD40 ligand (CD154); Common variable immunodeficiency (CVID)

Indexed keywords

CD40 LIGAND; CD69 ANTIGEN; IONOMYCIN; PHORBOL 13 ACETATE 12 MYRISTATE;

ADOLESCENT; ADULT; ARTICLE; CELL STIMULATION; CLINICAL ARTICLE; COMMON VARIABLE IMMUNODEFICIENCY; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HELPER CELL; HUMAN; MALE; PROTEIN EXPRESSION; SCHOOL CHILD;

ADOLESCENT; ADULT; ANTIBODIES, MONOCLONAL; CD40 LIGAND; CELLS, CULTURED; CHILD; COMMON VARIABLE IMMUNODEFICIENCY; FEMALE; HUMANS; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 35848934328     PISSN: 17351502     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Cunningham-Rundles C and Bodian C. Common variable immunodeficiency: clinical and immunological features of 248 patients. Clin Immunol 1999; 92(1):34-48.
2. Kokron CM, Errante PR, Barros MT, Baracho GV, Camargo MM, Kalil J, et al. Clinical and laboratory aspects of common variable immunodeficiency. An Acad Bras Cienc 2004; 76(4):707-26.
3. Aghamohammadi A, Farhoudi A, Moin M, Rezaei N, Kouhi A, Pourpak Z, et al. Clinical and immunological features of 65 Iranian patients with common variable immunodeficiency. Clin Diagn Lab Immunol 2005; 12(7):825-32.
4. Aghamohammadi A, Moin M, Farhoudi A, Pourpak Z, Rezaei N, Abolmaali K, et al. The clinical spectrum of respiratory disease in patients with primary antibody deficiency. Iran J Allergy Asthma Immunol 2000; 1(3),135-40.
5. Rezaei N, Aghamohammadi A, Moin M, Pourpak Z, Movahedi M, Gharagozlou M, et al. Frequency and clinical manifestations of patients with primary immunodeficiency disorders in Iran: update from the Iranian primary immunodeficiency registry. J Clin Immunol 2006; 26(6):519-32.
6. Spickett GP. Current perspectives on common variable immunodeficiency (CVID). Clin Exp Allergy 2001; 31(4):536-42.
7. Fuleihan R, Ramesh N, Loh R, Jabara H, Rosen RS, Chatila T, et al. Defective expression of the CD40 ligand in X chromosome-linked immunoglobulin deficiency with normal or elevated IgM. Proc Natl Acad Sci U S A 1993; 90(6):2170-3.
8. Allen RC, Armitage RJ, Conley ME, Rosenblatt H, Jenkins NA, Copeland NG, et al. CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome. Science 1993; 259(5097):990-3.
9. Aruffo A, Farrington M, Hollenbaugh D, Li X, Milatovich A, Nonoyama S, et al. The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome. Cell 1993; 72(2):291-300.
10. Korthäuer U, Graf D, Mages HW, Briere F, Padayachee M, Malcolm S, et al. Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM. Nature 1993; 361(6412):539-41.
11. DiSanto JP, Bonnefoy JY, Gauchat JF, Fischer A, De Saint Basile G. CD40 ligand mutations in x-linked immunodeficiency with hyper-IgM. Nature 1993; 361(6412):541-3.
12. Carsetti R, Rosado MM, Donnanno S, Guazzi V, Soresina A, Meini A, et al. The loss of IgM memory B cells correlates with clinical disease in common variable immunodeficiency. J Allergy Clin Immunol 2005; 115(2):412-7.
13. Farrington M, Grosmaire LS, Nonoyama S, Fischer SH, Hollenbaugh D, Ledbetter JA, et al. CD40 ligand expression is defective in a subset of patients with common variable immunodeficiency. Proc Natl Acad Sci U S A 1994; 91(3):1099-103.
14. Nonoyama S, Farrington M, Ishida H, Howard M, Ochs HD. Activated B cells from patients with common variable immunodeficiency proliferate and synthesize immunoglobulin. J Clin Invest 1993; 92(3):1282-7.
15. Boncristiano M, Bernardetta Majolini1 MB, D'Elios MM, Pacini S, Valensin S, Ulivieri C1, et al. Defective recruitment and activation of ZAP-70 in common variable immunodeficiency patients with T cell defects. Eur J Immunol 2000; 30:2632-38.
16. Spickett GP, Farrant J, North ME, Zhang JG, Morgan L and Webster AD. Common variable immunodeficiency: how many diseases? Immunol Today 1997; 18(7):325-8.